-
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NIAMS Withdrawal from PA-20-195 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Not Allowed"
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice to Extend the Expiration Date of PAR-20-255: Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Change to Submission Requirements for PAR-22-184: Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Termination of RFA-TR-22-013 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Special Interest: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Informational Webinar for PAR-23-138 "Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)"
at National Institutes of Health in Estados Unidos -
- Fellowship
- Posted 2 years ago
Update to Policy and Procedures for the Reporting of Human Subjects Enrollment Data for NIA Clinical Research Trials/Studies
at National Institutes of Health in Estados Unidos -
- Contract/Tender
- Posted 2 years ago
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology
at National Institutes of Health in Estados Unidos -
- Contract/Tender
- Posted 2 years ago
Notice of Termination of RFA-TR-22-011 HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Special Interest (NOSI): EXposome in Autoimmune Disease Collaborating Teams PLANning Awards (EXACT-PLAN) (Clinical Trials Not Allowed)
at National Institutes of Health in Estados Unidos -
- Contract/Tender
- Posted 2 years ago
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications.
at National Institutes of Health in Estados Unidos -
- Fellowship
- Posted 2 years ago
Notice of Change in Funding Opportunity Purpose of NIDCR Small Research Grants for Analyses of Existing Genomics Data (PAR-23-132)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Change of the Locus of Review, Application Types Allowed and Expiration date for PAR-23-097, "Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)"
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Termination of PAR-22-101 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Intent to Publish a Notice of Funding Opportunity for the PATCH-IN Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Change of the Locus of Review for PAR-23-102, "Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)"
at National Institutes of Health in Estados Unidos -
- Fellowship
- Posted 2 years ago
Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
at National Institutes of Health in Estados Unidos -
- Fellowship
- Posted 2 years ago
Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Correction to Section IV. Application and Submission Information for RFA-NS-24-022 "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)"
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of NIDCD Participation in PAR-21-251 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)" and PAR-21-252 Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
at National Institutes of Health in Estados Unidos -
- Research/Project Funding Opportunity
- Posted 2 years ago
Notice of Change to Application and Submission Information in RFA-AI-22-076, Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)
at National Institutes of Health in Estados Unidos -
- Fellowship
- Posted 2 years ago
Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed)
at National Institutes of Health in Estados Unidos